Genenet’s patented technology can be applied to any field that needs genetic engineering (eg medicine, synthetic biology and pharmaceutical industries). Genenet plan to offer genetic circuit design service, consultation service and patent licensing to academic or industrial research units. Their product could cover research units (including pharmaceutical companies and contract research organisation) world wide, with focus at high throughput drug discovery, CAR-T therapy and biomolecules detection.

There are many pain points in traditional biopharmaceutical research. For example, the high cost of research, time-consuming processes of drug development, and difficulties in treating complicated diseases. These problems not only harm the development of the biopharmaceutical industry, but also generate traumatic problems, such as COVID-19 pandemic, to our world. Genenet Technology provides a one-stop solution to address all these problems, in hope of taking the biopharmaceutical industry to the next level.